#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Refer to report.
This test is performed pursuant to an agreement with Roche Molecular Systems, Inc.
Please refer to Statement B in the Compliance Statements section in the front of the Laboratory Test Directory.
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistNote>
| Note: |
If KRAS is not detected, BRAF V600E Detection of Colon Cancer (Unstable Tumors) by PCR will be performed.
|
*ExistNote>
#ExistCPT>
| CPT Code(s): |
88381 Microdissection; 83907 Lysis; 83898 Amplification; 83904 Sequencing; 83912 Interpretation and report, if reflexed, add 83896 x2 Nucleic Acid Probes; 83898 Amplification - Additional CPT code modifiers may be required for procedures performed to test oncologic or inherited disorders.
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
Cetuximab (Erbitux), Panitumumab (Vectibix),, K-RAS Mutation Detection |
*ExistCrossReferences>